Andere Sprachen Edesa Biotech, Inc.

Aktien

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:01 03.05.2024			% 5 Tage	% 1. Jan.
4,632 ^USD	+1,70 %		+4,81 %	+1,37 %

05.03.	Top-Zuwächse vorbörslich	MT
09.02.	Edesa Biotech, Inc. meldet Ergebnis für das erste Quartal zum 31. Dezember 2023	CI

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference	12.04.
Edesa Biotech to Participate in Barclays Global Healthcare Conference	08.03.
Top Premarket Gainers	05.03.
Edesa Biotech, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	09.02.
Edesa Biotech, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	15.12.
Top Premarket Decliners	13.12.
Top Premarket Gainers	22.11.
Edesa Biotech, Inc. Reports Final Phase 2b Results for Dermatitis Study	20.11.
Regulators Approve Updated Phase 3 Trial Design for Edesa Biotech's ARDS Drug	26.10.23
Edesa Biotech, Inc. Approves Updated Phase 3 Trial Design for Edesa Biotech?S ARDS Drug	25.10.23
Top Premarket Decliners	13.10.23
Sector Update: Health Care Stocks Decline in Late Afternoon	12.10.23
Sector Update: Health Care	12.10.23
Top Midday Gainers	12.10.23
Edesa Biotech, Inc. to Receive Up to CAD 23 Million in Funding from Federal Government	12.10.23
Edesa Biotech to Implement 1-for-7 Reverse Share Split; Stock Declines	10.10.23
Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate	29.09.23
Edesa Biotech, Inc. Publishes Phase 2 Substudy Results of ARDS Drug Candidate	28.09.23
Edesa Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	09.08.23
Edesa Biotech's Ards Drug Inhibits Inflammation from Influenza and Other Pathogens	28.06.23

Keine Ergebnisse zu dieser Suche